These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38884321)
1. Small Step or Giant Leap? Expanding the Acute Stroke Thrombolysis Window to 24 Hours. Lee VH N Engl J Med; 2024 Jul; 391(3):273-275. PubMed ID: 38884321 [No Abstract] [Full Text] [Related]
2. Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection. Albers GW; Jumaa M; Purdon B; Zaidi SF; Streib C; Shuaib A; Sangha N; Kim M; Froehler MT; Schwartz NE; Clark WM; Kircher CE; Yang M; Massaro L; Lu XY; Rippon GA; Broderick JP; Butcher K; Lansberg MG; Liebeskind DS; Nouh A; Schwamm LH; Campbell BCV; N Engl J Med; 2024 Feb; 390(8):701-711. PubMed ID: 38329148 [TBL] [Abstract][Full Text] [Related]
3. Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy. Xiong Y; Campbell BCV; Schwamm LH; Meng X; Jin A; Parsons MW; Fisher M; Jiang Y; Che F; Wang L; Zhou L; Dai H; Liu X; Pan Y; Duan C; Xu Y; Xu A; Zong L; Tan Z; Ye W; Wang H; Wang Z; Hao M; Cao Z; Wang L; Wu S; Li H; Li Z; Zhao X; Wang Y; N Engl J Med; 2024 Jul; 391(3):203-212. PubMed ID: 38884324 [TBL] [Abstract][Full Text] [Related]
5. Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial. Parsons MW; Yogendrakumar V; Churilov L; Garcia-Esperon C; Campbell BCV; Russell ML; Sharma G; Chen C; Lin L; Chew BL; Ng FC; Deepak A; Choi PMC; Kleinig TJ; Cordato DJ; Wu TY; Fink JN; Ma H; Phan TG; Markus HS; Molina CA; Tsai CH; Lee JT; Jeng JS; Strbian D; Meretoja A; Arenillas JF; Buck BH; Devlin MJ; Brown H; Butcher KS; O'Brien B; Sabet A; Wijeratne T; Bivard A; Grimley RS; Agarwal S; Munshi SK; Donnan GA; Davis SM; Miteff F; Spratt NJ; Levi CR; Lancet Neurol; 2024 Aug; 23(8):775-786. PubMed ID: 38880118 [TBL] [Abstract][Full Text] [Related]
6. Evolving Thrombolytics: from Alteplase to Tenecteplase. Miller SE; Warach SJ Neurotherapeutics; 2023 Apr; 20(3):664-678. PubMed ID: 37273127 [TBL] [Abstract][Full Text] [Related]
7. Management of Acute Ischemic Stroke. Xiong Y; Manwani B; Fisher M Am J Med; 2019 Mar; 132(3):286-291. PubMed ID: 30832769 [TBL] [Abstract][Full Text] [Related]
8. A Phase III, prospective, double-blind, randomized, placebo-controlled trial of thrombolysis in imaging-eligible, late-window patients to assess the efficacy and safety of tenecteplase (TIMELESS): Rationale and design. Albers GW; Campbell BC; Lansberg MG; Broderick J; Butcher K; Froehler MT; Schwamm LH; Nouh AM; Liebeskind DS; Toy F; Yang M; Massaro L; Schoeffler M; Purdon B Int J Stroke; 2023 Feb; 18(2):237-241. PubMed ID: 35262424 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials. Wang Y; Cai X; Fang Q; Zhu J J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064 [TBL] [Abstract][Full Text] [Related]
10. Tenecteplase versus Alteplase before thrombectomy: A comprehensive evaluation of clinical and angiographic impact: Insights from the ETIS registry. Zarzour A; Batot C; Boisseau W; Cho TH; Guillon B; Richard S; Marnat G; Arquizan C; Lapergue B; Weisenburger Lile D; J Neuroradiol; 2024 Jun; 51(4):101189. PubMed ID: 38462131 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke. Wang L; Hao M; Wu N; Wu S; Fisher M; Xiong Y J Am Heart Assoc; 2024 May; 13(9):e031692. PubMed ID: 38686848 [TBL] [Abstract][Full Text] [Related]
12. Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study. Teivane A; Jurjāns K; Vētra J; Grigorjeva J; Kupcs K; Masiliūnas R; Miglāne E Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143846 [No Abstract] [Full Text] [Related]
13. In ischemic stroke, adding IV thrombolysis ≤2 h after symptom onset to thrombectomy was associated with benefit. Sebastian IA; Hill MD Ann Intern Med; 2024 Jun; 177(6):JC68. PubMed ID: 38830216 [TBL] [Abstract][Full Text] [Related]
14. Effect of continuous 2 MHz transcranial ultrasound as an adjunct to tenecteplase thrombolysis in acute anterior circulation ischemic stroke patients: an open labeled non-randomized clinical trial. Arumugham S; Narayan SK; Aghoram R J Thromb Thrombolysis; 2024 Jun; 57(5):788-796. PubMed ID: 38393673 [TBL] [Abstract][Full Text] [Related]
15. "Intraosseous administration of tenecteplase for thrombolysis of an acute ischemic stroke". Chung J; Bundy J; Khan S; Hunt A; Carroll S; Ali A; Shafi N; Tesoro E J Stroke Cerebrovasc Dis; 2024 Sep; 33(9):107850. PubMed ID: 38971481 [TBL] [Abstract][Full Text] [Related]
16. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol. Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938 [TBL] [Abstract][Full Text] [Related]